Mark T. Iwicki

Insider Reports History

Entity
Individual
Location
84 Waterford Drive, Marlborough, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark T. Iwicki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 264K $1.25M $4.75 Jun 26, 2024 Direct
Homology Medicines, Inc. Director Stock Option (Right to Buy) 25.5K $343K $13.42 Mar 25, 2024 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Direct
Merus N.V. Director Share Option (right to buy) 8.84K $120K $13.52 May 7, 2024 Direct
KALA BIO, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 64.5K Jan 4, 2024 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 26K Jun 8, 2024 Direct
Third Harmonic Bio, Inc. Director Director Stock Option (right to buy) 20K Jun 6, 2024 Direct

Insider Reports Filed by Mark T. Iwicki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 26, 2024 1 -$72K 4 Jun 27, 2024 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KALA KALA BIO, Inc. May 31, 2024 1 -$45K 4 Jun 3, 2024 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director
KALA KALA BIO, Inc. Jan 4, 2024 3 -$30.5K 4 Jan 5, 2024 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 2 $0 4 Jun 23, 2023 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 11 $0 4 Jun 2, 2023 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. Apr 14, 2023 4 $535K 4 Apr 17, 2023 Director
KALA Kala Pharmaceuticals, Inc. Mar 14, 2023 1 $0 4 Mar 15, 2023 CHIEF EXECUTIVE OFFICER, Director
THRD Third Harmonic Bio, Inc. Mar 6, 2023 4 $0 4 Mar 8, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jan 4, 2023 2 -$5.65K 4 Jan 6, 2023 CHIEF EXECUTIVE OFFICER, Director
KALA Kala Pharmaceuticals, Inc. Oct 26, 2022 1 -$3.66K 4 Oct 28, 2022 CHIEF EXECUTIVE OFFICER, Director
THRD Third Harmonic Bio, Inc. Oct 26, 2022 1 $0 4 Oct 27, 2022 Director
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 27, 2022 1 -$2.95K 4 Jun 29, 2022 CHIEF EXECUTIVE OFFICER, Director
AVTE Aerovate Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
MRUS Merus N.V. May 31, 2022 1 $0 4 Jun 2, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jan 3, 2022 2 -$12.4K 4 Jan 5, 2022 CHIEF EXECUTIVE OFFICER, Director
KALA Kala Pharmaceuticals, Inc. Oct 26, 2021 1 -$49.7K 4 Oct 28, 2021 CHIEF EXECUTIVE OFFICER, Director
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Director
KALA Kala Pharmaceuticals, Inc. Jun 28, 2021 1 -$43.8K 4 Jun 29, 2021 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director
MRUS Merus N.V. May 28, 2021 1 $0 4 Jun 2, 2021 Director
AVTE Aerovate Therapeutics, Inc. Apr 2, 2021 3 $0 4 Jul 1, 2021 Director